Biosimilars need comparative clinical data

被引：4

作者：

Casadevall, Nicole ^{[1
]}

Thorpe, Robin

Schellekens, Huub ^{[2
]}

机构：

[1] Hop St Antoine, F-75571 Paris, France

[2] Univ Utrecht, Fac Sci, Utrecht, Netherlands

来源：

KIDNEY INTERNATIONAL | 2011年 / 80卷 / 05期

关键词：

D O I：

10.1038/ki.2011.164

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

100201 [内科学]; 100221 [泌尿外科学];

摘要：

引用

收藏

页码：553 / 553

页数：1

相关论文

共 2 条

[1]

WHO informal consultation on regulatory evaluation of therapeutic biological medicinal products held at WHO Headquarters, Geneva, 19-20 April 2007 [J].

Joung, Jeewon ;

Robertson, James S. ;

Griffiths, Elwyn ;

Knezevic, Ivana .

BIOLOGICALS, 2008, 36 (04) :269-276

[2]

Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies [J].

Praditpornsilpa, Kearkiat ;

Tiranathanagul, Khajohn ;

Kupatawintu, Pawinee ;

Jootar, Saengsuree ;

Intragumtornchai, Tanin ;

Tungsanga, Kriang ;

Teerapornlertratt, Tanyarat ;

Lumlertkul, Dusit ;

Townamchai, Natavudh ;

Susantitaphong, Paweena ;

Katavetin, Pisut ;

Kanjanabuch, Talerngsak ;

Avihingsanon, Yingyos ;

Eiam-Ong, Somchai .

KIDNEY INTERNATIONAL, 2011, 80 (01) :88-92